Parkman Healthcare Partners as of March 31, 2025
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 91 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insulet Corporation (PODD) | 4.1 | $34M | 131k | 262.61 | |
| CVS Caremark Corporation (CVS) | 4.0 | $34M | 497k | 67.75 | |
| Eli Lilly & Co. (LLY) | 3.8 | $32M | 39k | 825.91 | |
| Stryker Corporation (SYK) | 3.4 | $29M | 78k | 372.25 | |
| Tenet Healthcare Corp Com New (THC) | 3.4 | $29M | 213k | 134.50 | |
| Becton, Dickinson and (BDX) | 3.3 | $28M | 120k | 229.06 | |
| Cooper Cos (COO) | 3.1 | $26M | 313k | 84.35 | |
| UnitedHealth (UNH) | 3.1 | $26M | 50k | 523.75 | |
| Gilead Sciences (GILD) | 2.9 | $25M | 219k | 112.05 | |
| Boston Scientific Corporation (BSX) | 2.7 | $23M | 226k | 100.88 | |
| Zimmer Holdings (ZBH) | 2.7 | $23M | 201k | 113.18 | |
| BioMarin Pharmaceutical (BMRN) | 2.3 | $20M | 277k | 70.69 | |
| Neurocrine Biosciences (NBIX) | 2.2 | $19M | 168k | 110.60 | |
| Alnylam Pharmaceuticals (ALNY) | 2.2 | $19M | 69k | 270.02 | |
| Travere Therapeutics (TVTX) | 2.0 | $17M | 954k | 17.92 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 2.0 | $17M | 763k | 22.21 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.0 | $17M | 260k | 63.49 | |
| Rxsight (RXST) | 1.9 | $16M | 631k | 25.25 | |
| CVRX (CVRX) | 1.8 | $15M | 1.2M | 12.23 | |
| McKesson Corporation (MCK) | 1.8 | $15M | 22k | 672.99 | |
| PerkinElmer (RVTY) | 1.8 | $15M | 140k | 105.80 | |
| Edwards Lifesciences (EW) | 1.7 | $15M | 201k | 72.48 | |
| Qiagen Nv Com Shs (QGEN) | 1.7 | $14M | 360k | 40.15 | |
| Miragen Therapeutics (VRDN) | 1.7 | $14M | 1.1M | 13.48 | |
| Ptc Therapeutics I (PTCT) | 1.7 | $14M | 280k | 50.96 | |
| Danaher Corporation (DHR) | 1.5 | $13M | 63k | 205.00 | |
| Mannkind Corp Com New (MNKD) | 1.5 | $13M | 2.5M | 5.03 | |
| Ultragenyx Pharmaceutical (RARE) | 1.3 | $11M | 304k | 36.21 | |
| Quest Diagnostics Incorporated (DGX) | 1.3 | $11M | 63k | 169.20 | |
| Axogen (AXGN) | 1.2 | $9.9M | 537k | 18.50 | |
| Xeris Pharmaceuticals (XERS) | 1.2 | $9.8M | 1.8M | 5.49 | |
| Arcus Biosciences Incorporated (RCUS) | 1.1 | $9.5M | 1.2M | 7.85 | |
| Schrodinger (SDGR) | 1.1 | $9.5M | 482k | 19.74 | |
| Edgewise Therapeutics (EWTX) | 1.1 | $9.4M | 425k | 22.00 | |
| Replimune Group (REPL) | 1.1 | $9.3M | 950k | 9.75 | |
| Dex (DXCM) | 1.1 | $8.9M | 130k | 68.29 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $8.7M | 754k | 11.54 | |
| Day One Biopharmaceuticals I (DAWN) | 1.0 | $8.3M | 1.0M | 7.93 | |
| Nuvalent Inc-a (NUVL) | 0.9 | $7.8M | 110k | 70.92 | |
| BioCryst Pharmaceuticals (BCRX) | 0.9 | $7.5M | 1.0M | 7.50 | |
| Syndax Pharmaceuticals (SNDX) | 0.9 | $7.3M | 595k | 12.29 | |
| Biosante Pharmaceuticals (ANIP) | 0.8 | $7.0M | 105k | 66.95 | |
| Castle Biosciences (CSTL) | 0.8 | $7.0M | 351k | 20.02 | |
| Livanova SHS (LIVN) | 0.8 | $6.6M | 167k | 39.28 | |
| Quidel Corp (QDEL) | 0.8 | $6.4M | 184k | 34.97 | |
| Treace Med Concepts (TMCI) | 0.7 | $6.0M | 714k | 8.39 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $5.9M | 175k | 33.55 | |
| Doximity Cl A (DOCS) | 0.6 | $5.4M | 94k | 58.03 | |
| ResMed (RMD) | 0.6 | $5.1M | 23k | 223.85 | |
| Veracyte (VCYT) | 0.6 | $4.9M | 166k | 29.65 | |
| Precigen (PGEN) | 0.6 | $4.8M | 3.2M | 1.49 | |
| Mineralys Therapeutics (MLYS) | 0.6 | $4.7M | 294k | 15.88 | |
| Amicus Therapeutics (FOLD) | 0.6 | $4.6M | 569k | 8.16 | |
| Alphatec Hldgs Com New (ATEC) | 0.5 | $4.5M | 446k | 10.14 | |
| Arcellx Common Stock (ACLX) | 0.5 | $4.4M | 67k | 65.60 | |
| Urogen Pharma (URGN) | 0.5 | $4.3M | 393k | 11.06 | |
| Nurix Therapeutics (NRIX) | 0.5 | $4.2M | 350k | 11.88 | |
| Pulmonx Corp (LUNG) | 0.5 | $4.1M | 612k | 6.73 | |
| Optimizerx Corp Com New (OPRX) | 0.5 | $4.1M | 475k | 8.66 | |
| Guardant Health (GH) | 0.5 | $3.8M | 89k | 42.60 | |
| Vaxcyte (PCVX) | 0.4 | $3.5M | 93k | 37.76 | |
| Si-bone (SIBN) | 0.4 | $3.2M | 231k | 14.03 | |
| United Therapeutics Corporation (UTHR) | 0.4 | $3.2M | 10k | 308.27 | |
| Inspiremd (NSPR) | 0.4 | $3.2M | 1.2M | 2.69 | |
| Performant Finl (PHLT) | 0.4 | $3.1M | 1.1M | 2.96 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.4 | $3.0M | 235k | 12.97 | |
| Insmed Com Par $.01 (INSM) | 0.3 | $2.9M | 38k | 76.29 | |
| CryoLife (AORT) | 0.3 | $2.7M | 112k | 24.58 | |
| Terns Pharmaceuticals (TERN) | 0.3 | $2.6M | 960k | 2.76 | |
| Outset Med Com New (OM) | 0.3 | $2.6M | 231k | 11.06 | |
| Mbx Biosciences (MBX) | 0.3 | $2.4M | 328k | 7.38 | |
| Keros Therapeutics (KROS) | 0.3 | $2.2M | 218k | 10.19 | |
| Uniqure Nv SHS (QURE) | 0.3 | $2.2M | 204k | 10.60 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.3 | $2.1M | 64k | 33.54 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.2 | $2.1M | 101k | 20.47 | |
| Rapid Micro Biosystems Class A Com (RPID) | 0.2 | $1.9M | 736k | 2.64 | |
| Vera Therapeutics Cl A (VERA) | 0.2 | $1.8M | 76k | 24.02 | |
| Apogee Therapeutics (APGE) | 0.2 | $1.7M | 47k | 37.36 | |
| Icad Com New (ICAD) | 0.2 | $1.6M | 782k | 2.06 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.2 | $1.5M | 660k | 2.21 | |
| Upstream Bio (UPB) | 0.2 | $1.4M | 234k | 6.12 | |
| Merus N V (MRUS) | 0.1 | $1.2M | 28k | 42.09 | |
| Silence Therapeutics Ads (SLN) | 0.1 | $1.1M | 402k | 2.82 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $1.1M | 203k | 5.58 | |
| Ardelyx (ARDX) | 0.1 | $1.0M | 210k | 4.91 | |
| Entera Bio SHS (ENTX) | 0.1 | $747k | 440k | 1.70 | |
| Annexon (ANNX) | 0.1 | $678k | 351k | 1.93 | |
| Relay Therapeutics (RLAY) | 0.1 | $493k | 188k | 2.62 | |
| Vyne Therapeutics (VYNE) | 0.0 | $344k | 218k | 1.58 | |
| Edap Tms S A Sponsored Adr (EDAP) | 0.0 | $304k | 155k | 1.96 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $302k | 205k | 1.47 |
